CNR Institutional Research Information System

FUSCO, ALFREDO

FUSCO, ALFREDO  

Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS  

Mostra records
Risultati 1 - 20 di 281 (tempo di esecuzione: 0.053 secondi).
Titolo Data di pubblicazione Autore(i) File
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma 1-gen-2023 De Martino, Marco; Pellecchia, Simona; Decaussin-Petrucci, Myriam; Testa, Domenico; Meireles Da Costa, Nathalia; Pallante, Pierlorenzo; Chieffi, Paolo; Fusco, Alfredo; Esposito, Francesco
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness 1-gen-2023 De Martino, Marco; Pellecchia, Simona; Esposito, Francesco; Liotti, Federica; Credendino, Sara Carmela; Prevete, Nella; Decaussin-Petrucci, Myriam; Chieffi, Paolo; De Vita, Gabriella; Melillo, Rosa Marina; Fusco, Alfredo; Pallante, Pierlorenzo
Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas 1-gen-2022 De Martino, Marco; Esposito, Francesco; Capone, Maria; Pallante, Pierlorenzo; Fusco, Alfredo
Critical role of the high mobility group A proteins in hematological malignancies 1-gen-2021 De Martino, Marco; Esposito, Francesco; Fusco, Alfredo
HMGA1 induces EZH2 overexpression in human B-cell lymphomas 1-gen-2021 De Martino, Marco; Nicolau-Neto, Pedro; Ribeiro Pinto, Luis Felipe; Traverse-Glehen, Alexandra; Bachy, Emmanuel; Gigantino, Vincenzo; De Cecio, Rossella; Bertoni, Francesco; Chieffi, Paolo; Fusco, Alfredo; Esposito, Francesco
MPPED2 is downregulated in glioblastoma, and its restoration inhibits proliferation and increases the sensitivity to temozolomide of glioblastoma cells 1-gen-2021 Pellecchia, Simona; De Martino, Marco; Esposito, Francesco; Quintavalle, Cristina; Fusco, Alfredo; Pallante, Pierlorenzo
Characterization of HMGA1P6 transgenic mouse embryonic fibroblasts 1-gen-2020 De Martino, M; Palma, G; Arra, C; Chieffi, P; Fusco, A; Esposito, F
HMGA1-pseudogene7 transgenic mice develop B cell lymphomas 1-gen-2020 De Martino M.; De Biase D.; Forzati F.; Credendino S.C.; Palma G.; Barbieri A.; Arra C.; Paciello O.; Gaudio E.; Ponzoni M.; Vita G.D.; Chieffi P.; Bertoni F.; Fusco A.; Esposito F.
HMGA1-regulating microRNAs let-7a and miR-26a are downregulated in human seminomas 1-gen-2020 De Martino M.; Esposito F.; Pellecchia S.; Penha R.C.C.; Botti G.; Fusco A.; Chieffi P.
Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays 1-gen-2020 Su, Linjia; Bryan, Nadezda; Battista, Sabrina; Freitas, Juliano; Garabedian, Alyssa; D'Alessio, Federica; Romano, Miriam; Falanga, Fabiana; Fusco, Alfredo; Kos, Lidia; Chambers, Jeremy; Fernandez-Lima, Francisco; Chapagain, Prem P; Vasile, Stefan; Smith, Layton; Leng, Fenfei
The HMGA1-pseudogene7 shows oncogenic activity in vivo 1-gen-2020 De Martino, Marco; Esposito, Francesco; Fusco, Alfredo
The long non-coding RNA prader willi/angelman region RNA5 (PAR5) is downregulated in anaplastic thyroid carcinomas where it acts as a tumor suppressor by reducing EZH2 activity 1-gen-2020 Pellecchia S.; Sepe R.; DecaussinPetrucci M.; Ivan C.; Shimizu M.; Coppola C.; Testa D.; Calin G.A.; Fusco A.; Pallante P.
A ceRNA circuitry involving the long noncoding RNA KLHL14-AS, PAX8, and BCL2 drives thyroid carcinogenesis 1-gen-2019 Credendino S.C.; Bellone M.L.; Lewin N.; Amendola E.; Sanges R.; Basu S.; Sepe R.; DecaussinPetrucci M.; Tinto N.; Fusco A.; de Felice M.; de Vita G.
Characterization of inflammatory infiltrate of ulcerative dermatitis in C57BL/6NCrl-Tg(HMGA1P6)1Pg mice 1-gen-2019 De Biase, Davide; Esposito, Francesco; DE MARTINO, Marco; Pirozzi, Claudio; Luciano, Antonio; Palma, Giuseppe; Raso Giuseppina, Mattace; Iovane, Valentina; Marzocco, Stefania; Fusco, Alfredo; Paciello, Orlando
Double knock-out of Hmga1 and Hipk2 genes causes perinatal death associated to respiratory distress and thyroid abnormalities in mice 1-gen-2019 Gerlini R.; Amendola E.; Conte A.; Valente V.; Tornincasa M.; Credendino S.C.; Cammarota F.; Gentile C.; Di Guida L.; Paladino S.; De Vita G.; Pierantoni G.M.; Fusco A.
HMGA and cancer: A review on patent literatures 1-gen-2019 De Martino M.; Fusco A.; Esposito F.
HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells 1-gen-2019 Puca, F; Tosti, N; Federico, A; Kuzay, Y; Pepe, A; Morlando, S; Savarese, T; D'Alessio, F; Colamaio, M; Sarnataro, D; Ziberi, S; De Martino, M; Fusco, A; Battista, S
Oncogenic Properties of the Antisense lncRNA COMET in BRAF- and RET-Driven Papillary Thyroid Carcinomas 1-gen-2019 Esposito, Roberta; Esposito, Daniela; Pallante, Pierlorenzo; Fusco, Alfredo; Ciccodicola, Alfredo; Costa, Valerio
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. 1-gen-2019 Capo A; Sepe R; Pellino G; Milone M; Malapelle U; Pellecchia S; Pepe F; Cacciola NA; Manigrasso M; Bruzzaniti S; Sciaudone G; De Palma GD; Galgani M; Selvaggi F; Troncone G; Fusco A; D'Auria S; Pallante P.
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. Nanomedicine. 1-gen-2019 Capo A; Sepe R; Pellino G; Milone M; Malapelle U; Pellecchia S; Pepe F; Cacciola NA; Manigrasso M; Bruzzaniti S; Sciaudone G; De Palma GD; Galgani M; Selvaggi F; Troncone G; Fusco A; D'Auria S; Pallante P.